Zurbay Donald 4
4 · Sight Sciences, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) Director Donald Zurbay Receives RSU Award
What Happened Donald Zurbay, a director of Sight Sciences, was granted 28,261 restricted stock units (RSUs) on June 4, 2026. The RSUs were issued at no cash cost (reported price $0.00) and are each convertible into one share of common stock. The grant was valued at approximately $130,000 based on the closing price on the grant date. The RSUs vest on the earlier of June 4, 2027 or the company's 2027 annual meeting, subject to Zurbay’s continued service as a director.
Key Details
- Transaction date: June 4, 2026; Filing date: June 5, 2026 (appears timely).
- Transaction type/code: Award/Grant (A); 28,261 RSUs granted at $0.00 acquisition price.
- Vesting: Earlier of June 4, 2027 or the 2027 annual meeting, subject to continued board service.
- Shares owned/beneficial position after grant (per footnote): 75,352 shares of common stock; plus 28,261 RSUs (unvested); and rights to acquire 90,000 shares via options exercisable within 60 days of June 4, 2026. If RSUs vest and options are exercised, potential total = 193,613 shares.
- No 10b5-1 plan, tax-withholding, or late-filing notes disclosed in the filing.
Context This is a routine non-employee director compensation award rather than an open-market purchase or sale. RSU grants are common for directors and do not require cash outlay; they only convert to tradable shares once vested (and then may be subject to company rules or holding periods). The filing lists exercisable options that could increase his stake if exercised, but exercising options is a separate transaction.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-04+28,261→ 193,613 total
Footnotes (2)
- [F1]Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date.
- [F2]Includes (i) 75,352 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 90,000 shares of Common Stock which the Reporting Person has the right to acquire upon the exercise of stock options exercisable within 60 days of June 4, 2026.